Cargando…

Risk of osteoporosis in testicular germ cell tumour survivors: A systematic review of the literature

CONTEXT: Testicular germ cell tumour (TGCT) survivors are potentially at risk of developing osteoporosis, because of increased risk for disturbed bone remodelling associated with hypogonadism and anti‐cancer treatment. A number of studies show bone loss and increased fracture risk in TGCT survivors,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vrouwe, Josephina P. M., Hennus, Pauline M. L., Hamdy, Neveen A. T., Osanto, Susanne, Willemse, Peter‐Paul M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766871/ https://www.ncbi.nlm.nih.gov/pubmed/36569500 http://dx.doi.org/10.1002/bco2.183

Ejemplares similares

Reply: ‘Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
por: Willemse, P M, et al.
Publicado: (2013)

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
por: Willemse, P M, et al.
Publicado: (2013)

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
por: Willemse, P M, et al.
Publicado: (2013)

Quantitative ultrasound of the calcaneus (QUS): A valuable tool in the identification of patients with non-metastatic prostate cancer requiring screening for osteoporosis
por: Nieuwkamer, B.B., et al.
Publicado: (2023)

Radiotherapy in testicular germ cell tumours – a literature review
por: Jonska-Gmyrek, Joanna, et al.
Publicado: (2017)

Imaging of testicular germ cell tumours
por: Dalal, P U, et al.
Publicado: (2006)

Comment on ‘Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
por: Singhera, M, et al.
Publicado: (2013)

Recent advances in testicular germ cell tumours
por: Mele, Teresa, et al.
Publicado: (2021)

Testicular Germ Cell Tumours and Proprotein Convertases
por: Velado-Eguskiza, Aitziber, et al.
Publicado: (2022)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

Testicular microlithiasis as a familial risk factor for testicular germ cell tumour
por: Coffey, J, et al.
Publicado: (2007)

IGF signalling in germ cells and testicular germ cell tumours: roles and therapeutic approaches
por: Selfe, J., et al.
Publicado: (2019)

Somatic mutations of KIT in familial testicular germ cell tumours
por: Rapley, E A, et al.
Publicado: (2004)

Long-term sequelae of treatment for testicular germ cell tumours.
por: Bissett, D., et al.
Publicado: (1990)

Bone disease in testicular and extragonadal germ cell tumours.
por: Hitchins, R. N., et al.
Publicado: (1988)

Microsatellite instability in human testicular germ cell tumours.
por: Huddart, R. A., et al.
Publicado: (1995)

Glycolipids of human primary testicular germ cell tumours.
por: Olie, R. A., et al.
Publicado: (1996)

Clinical and genetic aspects of testicular germ cell tumours
por: Holzik, Martijn F Lutke, et al.
Publicado: (2008)

Cutaneous metastasis from testicular germ cell tumour
por: Joel, Anjana, et al.
Publicado: (2014)

Scrotal Involvement with Testicular Nonseminomatous Germ Cell Tumour
por: O'Leary, C. G., et al.
Publicado: (2016)

Testicular Germ Cell Tumours—The Role of Conventional Ultrasound
por: Belfield, Jane, et al.
Publicado: (2022)

Risk and prognostic significance of metachronous contralateral testicular germ cell tumours
por: Schaapveld, M, et al.
Publicado: (2012)

Risk of testicular germ-cell tumours in relation to childhood physical activity
por: Cook, M B, et al.
Publicado: (2008)

Regressed testicular germ cell tumour in a post-pubertal male
por: Pickett, Lianne, et al.
Publicado: (2022)

The role of surgery in metastatic testicular germ cell tumours (GCT).
por: Newlands, E. S., et al.
Publicado: (1989)

Long term deficiency of vitamin D in germ cell testicular cancer survivors
por: Nappi, Lucia, et al.
Publicado: (2018)

An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer
por: Vrouwe, Josephina P. M., et al.
Publicado: (2021)

Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours
por: Nitzsche, B, et al.
Publicado: (2010)

Genomic copy number and expression patterns in testicular germ cell tumours
por: McIntyre, A, et al.
Publicado: (2007)

Identification of four new susceptibility loci for testicular germ cell tumour
por: Litchfield, Kevin, et al.
Publicado: (2015)

No evidence for seasonal variations of the incidence of testicular germ cell tumours in Germany
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2023)

Late Relapse and Follow-up Protocols in Testicular Germ Cell Tumours: The Edinburgh Cancer Centre Experience and Review of the Literature
por: Detti, Beatrice, et al.
Publicado: (2008)

DICER1 RNase IIIb domain mutations are infrequent in testicular germ cell tumours
por: de Boer, Carmela M, et al.
Publicado: (2012)

Lack of Bcl10 mutations in testicular germ cell tumours and derived cell lines
por: Schothorst, E M van, et al.
Publicado: (1999)

Testicular mixed germ cell tumour with isolated skip metastasis to unilateral pleura: First case reported in the literature
por: Kamat, Manmohan, et al.
Publicado: (2019)

Increased risk of testis failure in testicular germ cell tumor survivors undergoing radiotherapy
por: Ghezzi, Marco, et al.
Publicado: (2017)

Cognitive impairment and biomarkers of gut microbial translocation in testicular germ cell tumor survivors
por: Chovanec, Michal, et al.
Publicado: (2023)

The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
por: Peckham, M. J., et al.
Publicado: (1983)

Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours
por: McNeish, I A, et al.
Publicado: (2004)

Expression of Syndecan-4 and Correlation with Metastatic Potential in Testicular Germ Cell Tumours
por: Labropoulou, Vassiliki T., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ilae4js12clm4e7e2he8qk5e89